SCHEMBL5793544

SCHEMBL5793544

CCCCCCOCC(O)COC(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.50
HTT P42858 1/20 0.49
LPAR5 Q9H1C0 1/20 0.47
SPHK1 Q9NYA1 1/20 0.42
PLA2G4B P0C869 2/20 0.42
PLA2G2A P14555 2/20 0.41
PLA2G10 O15496 1/20 0.41
PLA2G1B P04054 1/20 0.41
PLA2G5 P39877 1/20 0.41
PLA2G2C Q5R387 1/20 0.40
TK1 P04183 1/20 0.40
CTSK P43235 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
KIF11 P52732 1/20 0.38
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13105319 1.00 USP2 (0.50) USP2HTTLPAR5SPHK1PLA2G4B
SCHEMBL1965094 1.00 USP2 (0.50) USP2HTTLPAR5SPHK1PLA2G4B
SCHEMBL2231718 1.00 USP2 (0.50) USP2HTTLPAR5SPHK1PLA2G4B
SCHEMBL25289434 1.00 USP2 (0.50) USP2HTTLPAR5SPHK1PLA2G4B
SCHEMBL2220171 1.00 USP2 (0.50) USP2HTTLPAR5SPHK1PLA2G4B
SCHEMBL25243275 1.00 USP2 (0.50) USP2HTTLPAR5SPHK1PLA2G4B
SCHEMBL10950109 1.00 USP2 (0.50) USP2HTTLPAR5SPHK1PLA2G4B
SCHEMBL25289433 1.00 USP2 (0.50) USP2HTTLPAR5SPHK1PLA2G4B
SCHEMBL2311830 1.00 USP2 (0.50) USP2HTTLPAR5SPHK1PLA2G4B
SCHEMBL2213869 1.00 USP2 (0.50) USP2HTTLPAR5SPHK1PLA2G4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006029081-A2 NUCLEOSIDE-LIPID CONJUGATES, THEIR METHOD OF PREPARATION AND USES THEREOF NEOPHARM, INC. (US) 2006-03-16 WO disclosed